Bright Minds Biosciences
DRUG
8 hedge funds and large institutions have $330K invested in Bright Minds Biosciences in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
33% more funds holding
Funds holding: 6 → 8 (+2)
7% more capital invested
Capital invested by funds: $309K → $330K (+$20.6K)
0.97% more ownership
Funds ownership: 5.59% → 6.56% (+0.97%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$28.8K |
| 2 |
Renaissance Technologies
New York
|
+$17.1K |
| 3 |
HF
HRT Financial
New York
|
+$4.96K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$888 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$260 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$3.86K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
AdvisorShares Investments
Bethesda,
Maryland
| $273K | +$28.8K | +20,189 | +12% |
|
|
HF
2
HRT Financial
New York
| $24K | +$4.96K | +3,475 | +26% |
|
|
3
Renaissance Technologies
New York
| $17K | +$17.1K | +11,996 | New |
|
|
VF
4
Virtu Financial
New York
| $15K | -$3.86K | -2,705 | -21% |
|
|
5
UBS Group
Zurich,
Switzerland
| $889 | +$888 | +622 | New |
|
|
APC
6
Aspire Private Capital
Cornelius,
North Carolina
| $143 | – | – | – |
|
7
BlackRock
New York
| $1 | – | – | – |
|
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$260 | +182 | +190% |
|
DRUG Hedge Fund Activity: Q4 2023 in Review
8 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Bright Minds Biosciences (DRUG) for Q4 2023, worth a combined $330K — up 6.7% from $309K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new DRUG positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was AdvisorShares Investments, adding an estimated $28.8K. The largest seller was Virtu Financial, cutting an estimated $3.86K.
- 8 institutional investors held Bright Minds Biosciences (DRUG) as of Q4 2023, up from 6 in Q3 2023.
- Funds reported $330K of Bright Minds Biosciences stock for Q4 2023, up 6.7% quarter-over-quarter.
- 2 funds opened new Bright Minds Biosciences positions in Q4 2023 and 0 closed out, a net change of +2 holders.
- The largest Bright Minds Biosciences buyer in Q4 2023 was AdvisorShares Investments, an estimated $28.8K added.
- The largest Bright Minds Biosciences seller in Q4 2023 was Virtu Financial, an estimated $3.86K sold.
Based on aggregated 13F filings for Q4 2023.